Fig. 3From: The pharmacokinetics, bioavailability and excretion of bergapten after oral and intravenous administration in rats using high performance liquid chromatography with fluorescence detectionThe mean plasma concentration–time profiles of bergapten after oral (a) and intravenous (b) administration (n = 8, mean ± SD)Back to article page